Utility of interferons in clinical radiotherapy
Abstract
Interferons are being tested in the treatment of a wide range of malignancies. Clinical experience has indicated that interferons may have relatively few side effects compared to other commonly used antineoplastic agents. In addition, they have shown activity as radiation response modifiers in various experimental systems. Thus, as natural biological compounds, interferons may prove to be superior to other radiation response modifiers now on clinical trial in radiotherapy. In this paper radiation-interferon interactions are reviewed and the evaluation of the usefulness of interferons as an adjuvant in radiotherapy is discussed.
Similar articles
-
[Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].Strahlenther Onkol. 2004 Apr;180(4):187-93. doi: 10.1007/s00066-004-9119-x. Strahlenther Onkol. 2004. PMID: 15057428 Review. German.
-
The role of radiosensitizing drugs in the management of cancer.Invest Cell Pathol. 1979 Oct-Dec;2(4):303-8. Invest Cell Pathol. 1979. PMID: 396284 Review.
-
Radiation modifiers: treatment overview and future investigations.Hematol Oncol Clin North Am. 2006 Feb;20(1):119-39. doi: 10.1016/j.hoc.2006.01.012. Hematol Oncol Clin North Am. 2006. PMID: 16580560 Review.
-
Interferons: biological and clinical effects.Semin Surg Oncol. 1989;5(6):391-401. doi: 10.1002/ssu.2980050605. Semin Surg Oncol. 1989. PMID: 2480628 Review.
-
International Clinical Trials in Radiation Oncology. Chemical modifiers.Int J Radiat Oncol Biol Phys. 1988;14 Suppl 1:S39-49. Int J Radiat Oncol Biol Phys. 1988. PMID: 3292481 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources